He subject of this call for tenders is to address methodological issues to foster joint HTA work supporting EU cooperation in this area. The service is expected to cover the following key:
(1) Advance development of HTA methodology to be applied when carrying out joint work (i.e. Joint Clinical Assessments (henceforth ‘JCA’) and Joint Scientific Consultations (henceforth ‘JSC’). (1). Joint HTA work including:
(a) 8 JSC for medicinal products or at least, not less than 6 and not more than 12 JSC; and
(b) 2 JCA for medicinal products or 4 collaborative assessments (CA) for medical devices, not less than 1 JCA for medicinal products or 2 CA for medical devices and not more than 2 JCA or 4 CA respectively.
He subject of this call for tenders is to address methodological issues to foster joint HTA work supporting EU cooperation in this area. The service is expected to cover the following key:
(1) Advance development of HTA methodology to be applied when carrying out joint work (i.e. Joint Clinical Assessments (henceforth ‘JCA’) and Joint Scientific Consultations (henceforth ‘JSC’). (1). Joint HTA work including:
(a) 8 JSC for medicinal products or at least, not less than 6 and not more than 12 JSC; and
(b) 2 JCA for medicinal products or 4 collaborative assessments (CA) for medical devices, not less than 1 JCA for medicinal products or 2 CA for medical devices and not more than 2 JCA or 4 CA respectively.
